Showing results (1371-1380 of 4,942) with videos related to

Sort By:
Pageof 495
Infection and Drug Resistance|February 7, 2022
Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort StudyThamer A Almangour, Leen Ghonem, Ahmad Aljabri, et al.
Infection and Drug Resistance|April 8, 2022
Clinical Analysis of 44 Children with Subacute Necrotizing LymphadenitisYue Zheng, Yue Du, Wan-Hong Zhu, et al.
Infection and Drug Resistance|March 25, 2022
Fatal Mucormycosis Post COVID-19 Infection in Uncontrolled Diabetes with Misuse of Glucocorticoids and AntibioticsHeba Hamed, Raed Madia, Hosniyeh Ladadweh, et al.
Infection and Drug Resistance|March 1, 2022
An Excretory Protein of Echinococcus multilocularis Inhibits Complement Classical Pathway ActivationYiwen Qiu, Shu Shen, Yi Yang, et al.
Infection and Drug Resistance|March 10, 2022
Clinical Perspective of Antimicrobial Resistance in BacteriaYing Zhu, Wei E Huang, Qiwen Yang
Infection and Drug Resistance|February 25, 2022
Evaluating the Prevalence and the Risk Factors of Gram-Negative Multi-Drug Resistant Bacteria in Eastern Saudi ArabiaAisha S Al Hamdan, Amal A Alghamdi, Ghada F Alyousif, et al.
Infection and Drug Resistance|March 4, 2022
Nosocomial Infection and Antibiotic-Resistant Threat in the Middle EastNabil A Nimer
Infection and Drug Resistance|June 27, 2019
Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patientsChia-Jung Liu, Tai-Fen Lee, Sheng-Yuan Ruan, et al.
Infection and Drug Resistance|April 18, 2019
Eugenol, a potential schistosomicidal agent with anti-inflammatory and antifibrotic effects against Schistosoma mansoni, induced liver pathologyAsmaa M El-Kady, Alzahraa Abdelraouf Ahmad, Tasneem M Hassan, et al.
Pageof 495